Related Experiment Video
Updated: Nov 11, 2025

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
Published on: October 20, 2023
Differentiating Induced Pluripotent Stem Cells Toward Mesenchymal Stem/Stromal Cells.
Shennea S McGarvey1,2, Michael Ferreyros1,2, Igor Kogut1,2
1Department of Dermatology, University of Colorado School of Medicine, Aurora, CO, USA.
Generating mesenchymal stem/stromal cells (MSCs) from human induced pluripotent stem cells (iPSCs) is crucial for therapy. This study optimizes MSC production from iPSCs using embryoid bodies and TGF-β1, achieving high efficiency and cell stability.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Cell therapy
Background:
- Human induced pluripotent stem cells (iPSCs) can be differentiated into various cell types.
- Mesenchymal stem/stromal cells (MSCs) are valuable for therapeutic applications.
- Current methods for deriving MSCs from iPSCs have low efficiency.
Purpose of the Study:
- To develop an optimized protocol for efficient MSC derivation from human iPSCs.
- To improve the yield and characteristics of iPSC-derived MSCs for therapeutic use.
Main Methods:
- Generation of embryoid bodies (EBs) from human iPSCs.
- Treatment of EBs with transforming growth factor beta 1 (TGF-β1).
- Purification of MSCs based on CD73, CD105, and CD90 marker expression.
Main Results:
- Achieved high-efficiency production of MSCs from human iPSCs.
- Confirmed MSC characteristics after multiple passages.
- Demonstrated the therapeutic potential of iPSC-derived MSCs.
Conclusions:
- The optimized protocol significantly enhances MSC derivation from iPSCs.
- iPSC-derived MSCs maintain their therapeutic properties upon expansion.
- This method provides a renewable and efficient source of clinical-grade MSCs.
Related Concept Videos
iPS Cell Differentiation
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Stem Cell Culture
Source And Potency Of Stem Cells

